Target intelligence / Profile preview

U6 small nuclear RNA 119 pseudogene (RNU6-119P)

Target
RNU6-119P
Molecular classification
Other (processed pseudogene), Small nuclear RNA pseudogene
01

Overview

U6 small nuclear RNA pseudogenes, such as RNU6-119P, are processed genomic sequences derived from the U6 snRNA gene. U6 snRNA itself is an essential component of the spliceosome and is involved in coordinating catalytic reactions required for intron removal during pre-mRNA processing[2][3]. Pseudogenes like RNU6-119P arise through retrotransposition events—often mediated by LINE elements—resulting in non-functional genomic copies[1][4]. These pseudogenes are prevalent throughout the genome and can serve as markers for retrotranspositional activity. However, they do not encode functional RNA molecules and have no direct role as therapeutic targets, biological regulators, or disease markers[4]. In summary, RNU6-119P designates a noncoding, processed pseudogene derived from U6 small nuclear RNA. While U6 snRNA itself is critical for intron splicing in eukaryotes, its pseudogenes, including RNU6-119P, do not contribute to cellular activities and are not considered targets for therapeutic intervention[2][3][4].

Other names
RNU6-119PRNA, U6 small nuclear 119, pseudogeneU6 snRNA pseudogene 119
02

Biological functions

Other (no known direct biological function; pseudogenes are generally non-functional remnants of evolutionary genomic processes[1][4])
03

Disease associations

Other (no established role in disease; pseudogenes generally do not encode proteins or have direct biological activity[4])

Beyond the preview

Go deeper on U6 small nuclear RNA 119 pseudogene (RNU6-119P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on U6 small nuclear RNA 119 pseudogene (RNU6-119P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call